ACTIV-2: A Study for Outpatients With COVID-19
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Links
- FDA Safety Alerts and Recalls CDC (Centers for Disease Control and Prevention): Coronavirus (COVID-19) website A Participant's Guide to Clinical Trials (NIAID) Find a Clinical Trial (NIAID) Clinical Trials at NIAID National Institute for Allergy and Infectious Diseases (NIAID) NIH COVID-19 treatment guidelines WHO COVID-19 treatment guidelines NIH: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)
- ID
- NCT04518410
- Phase
- Phase 2/3
- Study Type
- Interventional
- Last Updated